Introduction
Respiratory syncytial virus (RSV) and influenza virus are among the most important respiratory tract pathogens (Stott and Taylor, 1985) . Although some compounds (Le., amantadine and ribavirin) have been introduced for the treatment of RSV and influenza virus infections, they have demonstrated side effects and/or lead to the emergence of virus-drug resistance (Hall et al., 1983; Wilson et al., 1984; Dolin, 1985) . Sulfated polysaccharides, such as dextran sulfate and pentosan polysulfate, are potent and selective inhibitors of the in vitro replication of human immunodeficiency virus (HIV), myxoviruses (i.e., influenza A virus and RSV), and other enveloped viruses, Le., herpesvirus (herpes simplex Virus, cytomegalovirus [CMVj) , rhabdoviruses (vesicular stomatitis virus), togaviruses (Sindbis virus) and arenaviruses (Junin virus, Tacaribe virus) (Ito et al., 1987; Baba et el., 1988b; Andrei and De Clercq, 1990; Hosoya et al., 1991) . The sulfate groups, but not the sugar moieties, are essential for antiviral activity, since sulfated polymers, such as polyvinylalcohol sulfate (PVAS) and a copolymer of acrylic acid and vinylalcohol sulfate (PAVAS), have proved also to be efficient inhibitors of enveloped viruses Schols et al., 1990) . Their mode of action can be attributed to inhibition of virus adsorption to the cell membrane, as shown, in particular, for HIV and CMV (Baba et et., 1988a; Neyts et el., 1992) .
Previous studies have demonstrated that several naphthalenesulfonic acid derivatives are selective inhibitors of HIV and CMV (Mohan et al., 1991a (Mohan et al., , 1991b Baba et el., 1993) . New hybrid molecules have now been synthesized with naphthalenesulfonic acid linked to cholesterol (Fig. 1) , and their activities investigated against myxoviruses (RSV, influenza A and B virus) have been investigated. Although neither naphthalenesulfonic acid nor cholesterol were active against these myxoviruses, the hybrid molecules proved highly potent and selective inhibitors of both RSV and influenza-A virus.
Results
Naphthalenesulfonic acids, cholesterols and their hybrid molecules were evaluated for their inhibitory effects on the cytopathogenicity of myxoviruses in HeLa cells and MOCK cells (Table 1) . Although the single molecules (compounds 1-5) were not active against RSV, influenza A and B virus, the hybrid compounds 6 and 7 inhibited RSV and influenza A virus replication at a 50% inhibitory concentration (IC 5 0 ) of 4-20 fl9 mr". These activities were comparable to those of dextran sulfate that was included as a positive control. Like dextran sulfate, hybrid compounds 6 and 7 showed little, if any, activity against influenza B virus. Hybrid compound 8 proved inactive against all viruses. The minimum cytotoxic concentration (MCG) of hybrid compounds 6 and 7, as evaluated by a Hybrid compounds 6 and 7 each consist of two single molecules, i.e., compounds 1 and 5, and compounds 2 and 5, respectively (Fig. 1) . Whether a mixture (at a ratio of 1:1) of the two components corresponding to the hybrid molecule inhibit myxovirus-induced cytopathogenicity was investigated in this study. Mixtures of compounds 1 and 5, or compounds 2 and 5, did not show any activity against myxoviruses ( Table 2 ). The results suggest that naphthalenesulfonic acid chemically linked to cholesterol is required for anti-RSV activity as well as antiinfluenza A virus activity.
The inhibitory effects of hybrid compounds 6 and 7 on RSV and influenza A virus were determined following incubation of the test compounds with the cells at different times and temperatures. When present either during the 1h virus adsorption period at 4°C or 35°C, or immediately after virus adsorption for 1 h at 4°C or 35°C, the hybrid compounds 6 and 7 were capable of inhibiting the replication of RSV (Table 3) . When the reference compound, dextran sulfate, was added after the virus adsorption had Naphthalene sulfonic acid 1 >200 >200 >200 > 200 >200 2 >200 >200 >200 >200 >200 3 >200 >200 >200 >200 >200 Cholesterol 4 >200 >200 >200 >200 >200 5 >200 >200 >200 >200 >200 Hybrid molecule 6.5(6-7) 15 (10-20) >200 7 7.0 (4-10) 7 (4-10) >200
a See footnote a to Table 1. taken place at 35°C, it no longer inhibited RSV replication in HeLa cells. When the test compounds were added either during 1 h virus adsorption period at 35°C, or immediately after virus adsorption for 1 h at either 4 or 35°C, compounds 6 and 7 were effective in suppressing the replication of influenza A virus (Table 4) . However, the test compounds were ineffective when present only during virus adsorption at 4°C. Dextran sulfate was effective when it was added after influenza-A virus adsorption (for 1h at either 4°C or 35°C) had taken place at 35°C. These results indicate that the hybrid compounds 6 and 7 must interfere with the virus-cell binding (RSV) and/or virus-cell fusion (RSV and influenza-A virus).
Discussion
The study described here demonstrated that cholesterollinked naphthalenesulfonic acids (compounds 6 and 7) possess activity against RSV and influenza A virus, but not influenza S virus. Hosoya et al., 1991; Mohan et al., 1992) . These findings indicate that the sulfate or sulfonate groups are essential for antiviral activity, whereas the sugar moieties Table 3. are et aI., 1991a , 1991 Saba et al., 1993) . However, none of the sulfonic acid containing naphthalene derivatives (compounds 1-3) proved active against myxoviruses. Saba et al. (1993) also demonstrated that a compound acetylated at the amino group of compound 3 is not active against CMV. However, if a palmitoyl group is implanted at this nitrogen, the compound is active. Introduction of a fatty acid (palmitic acid) or cholesterol into the naphthalene sulfonic acid molecule may be essential for conferring antiviral activity, since naphthalene sulfonic acids covalently hybridized with cholesterol, but not the mixtures, inhibit RSV and influenza A virus replication. RSV (paramyxovirus) infection is initiated by adsorption of the virus (via the viral G glycoprotein) to receptors on the target cells. Then, the viral genome is internalized into the cell by fusion of the viral envelope with the plasma membrane through mediation of the viral F glycoprotein. Interaction of the viral G glycoprotein with the cellular receptor can occur at a low tempe' §.\ture (4°C), but viruscell fusion requires a higher te1'f:!perature (i.e., 35°C) (Choppin and Scheid, 1980) . Influenza virus (orthomyxovirus) binds to the target cell-surface receptor through the viral HA1 glycoprotein. Virus adsorption is followed by a process of receptor-mediated endocytosis, whereby the viral envelope fuses with the endosomal membrane and the virus genome is released into the cytoplasm. This process is mediated by the HA2 Viral glycoprotein. Endocytosis cannot occur at a low temperature (4°C). Thus, the 1 h incubation at 4°C permits adsorption of the virus to the cells but not endocytosis. The latter process requires a higher temperature (35°C) (White et al., 1981) .
The results obtained with the hybrid compounds (6 and 7) and dextran sulfate against RSV (Table 3) suggest that they inhibit both virus-cell binding and virus-cell fusion. However, the data presented in Table 4 suggest that these compounds do not inhibit the adsorption (or endocytosis) of influenza A virus. Probably, they inhibit influenza A virus replication at a step subsequent to virus adsorption, which may well correspond to virus-cell fusion. As demonstrated previously by Saba et al. Mitsuya et al. (1988) , Schols et al. (1989) and Neyts et al. (1992) , dextran sulfate interferes with the HIV or CMV replicative cycle atthe virus-cell binding step. The observations of LOscher-Mattli (1990) , who found that dextran sulfate inhibits fusion of influenza A virus with liposomal membranes, and the findings of the study described here indicate that the inhibitory effect of cholesterol-linked naphthalenesulfonic acids on the replication of influenza A virus is due to specific inhibition of virus-cell fusion rather than virus-cell binding (adsorption).
In conclusion, hybrid compounds containing naphthalene sulfonic acids linked to cholesterol were found to exert a selective inhibitory effect on RSV and influenza-A virus replication. The hybrid compounds inhibit an early step in the virus replicative cycle, which can be identified as virus-cell fusion (influenza-A virus) or both virus-cell binding ana fusion (RSV).
Materials and Experimental procedures
Compounds 4-Amino-1-naphthalenesulfonic acid (1). A Commercial sample of 4-amino-1-naphthalenesulfonic acid (Aldrich, Milwaukee, WI) was recrystallized from H 20:con H 2S04 (9:1). The resulting crystalline solid was filtered and used for the subsequent reactionswithout any further purification.
4-Amino-1,S-naphthalenedisulfonic acid (2).
A commercial sample of 4-amino-1 ,5-naphthalenesulfonic acid, monosodium salt (TCI America, Portland, OH) was loaded onto a short gel permeation column. Pure fractions were collected and evaporated to dryness to yield the starting material for subsequent reactions without any further purification.
4-Amino·S-hydroxy-2,7-naphthalenedisulfonic acid (3).
After one recrystallization from methanol-water (5:1), a commercial sample of 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid, monosodium salt (Aldrich), was dissolvedin water and put onto a column of weakly basic anion-exchange resin. The compound was eluted and recrystallized.
Cholesterol (4). A commercial sample of cholesterol (Aldrich) was recrystallized once from hot ethanoland the resultingcrystalline solid was filtered and used without further purification.
Cholesteryl chloroformate (5). A commercial sample of cholesteryl chloroformate (Aldrich) was used without any purification.
4-(3-Cholesterylcarbamate)-1-naphthalenesulfonic acid (6).
A mixture of 4-amino-1-naphthalenesulfonic acid (0.3g, 1.35 mmol), cholesteryl chloroformate (0.65g, 1.45mmol) and pyridine (3 ml) was stirred at 45-50°C for 20 h. The resulting mixture was evaporated under vacuumto removepyridine and the residuewas washedwith heptaneseveraltimes. Methanolwas added, the solution filtered and the filtrate evaporated to dryness to yield a solid which was recrystallized from methanolwater (9:1) twice to yield a pink powder (60mg, 7.0%): m.p 247-248°C; IR 3458,3204,2947 , 1703 , 1529 , 1500 , 1468 , 1383 , 1331 , 1219 , 1045 , 1012 , 70.81; H, 8.39. Found: C, 70.95; H, 8.12 .
4-(3-Cholesterylcarbamate)-1,S-naphthalenedisulfonic acid (7).
A mixture of 4-amino-1,5-naphthalenedisulfonic acid monosodium salt (0.2g, 0.62 mmol), cholesteryl chloroformate (0.28 g, 0.62 mmol) and pyridine (3 ml) was stirred at 45-50°C for 36 h. The resulting mixture was evaporated to remove pyridine and the residue was washed several times with heptane. Methanol (20 ml) was added and the mixture was filtered. The filtrate was evaporated to dryness to produce a pink solid (200 mg). A portion of this solid (50 mg) was put onto a short gel permeation column and run through twice. Evaporation of pure fractions yielded the product as a pink powder (30 mg, 6.5%): m.p. 229-230°C (dec); IR 3433, 2945 IR 3433, , 2868 IR 3433, , 1701 IR 3433, , 1545 IR 3433, , 1402 IR 3433, , 1335 IR 3433, , 1232 IR 3433, , 1194 IR 3433, , 1036 NMR 8 11.64 (s, 1H) . 4-Amino-5-hYdroxy-2,7-naphthalenedisulfonic acid (2.05 g, '6 mmol), cholesteryl chloroformate (2.92 g, 6.5 mmol) were reacted together at 50°C for 15 min and then anhydrous pyridine (15ml) was added. This reaction will be described elsewhere (P. Mohan et al., personal communication) .
Dextran sulfate (MW 5000) was purchased from Sigma Chemical Co. (S1. Louis, MO).
Viruses and cells
RSV (strain Long) was propagated in HeLa (a human epithelial cell line derived from a cervix carcinoma) (Kawana et al., 1987) . Influenza A virus (strain Ishikawal7/82 [H3N2)) and influenza B virus (strain Singapore/222/79) were grown in MOCK (Madin-Darby canine kidney) epithelial cells (Shigeta et al., 1988) . These viruses were stored at -80°C until use. For cultivation of the cells, Eagle's minimum essential medium (MEM) supplemented with 3 mM glutamine, 0.07% bicarbonate and 10% fetal calf serum (FCS) was used. In the maintenance medium (added after virus infection) the FCS concentration was only 1%.
Assays for antiviral activity
The procedures for measuring anti-myxovirus activity have been described previously (Kawana et aI., 1987; Shigeta et al., 1988; Hosoya et al., 1991) . Briefly, confluent cell cultures (HeLa [RSV] or MOCK [influenza A and B virus] cells) were seeded in 96-well microtitre plates and inoculated with virus at 20 times the 50% cell culture infective dose (CCID so) per well in the presence of various concentrations of the test compounds. After 5 days of incubation, virus-induced cytopathogenicity was recorded. The concentration of compound required to inhibit the appearance of virus-induced cytopathic effect by 50% was determined as the 50% inhibitory concentration (IC so). The experiments were carried out two or more times and mean IC so values are provided.
Influence of the incubation time period and incubation temperature on the antiviral activity of cholesterol-linked naphthalenesulfonic acids
Cells were seeded in wells of 96-well microlitre plates. After 2 days of incubation, the culture medium was removed, and 0.1 ml of maintenance medium with or without the test compounds and 0.1 ml of virus suspension containing 50 CCID so were added to each well. After 1 h incubation at 4 or 35°C, medium containing unadsorbed virus was removed, and the cell cultures were washed gently twice with MEM. Then, 0.2 ml of maintenance medium without or with the test compounds were added to the cell cultures. After 5 days of incubation at 35°C, the IC so values were determined (Ikeda et al., 1993) .
Cytotoxicity assay
Direct cytotoxicity of the compounds was evaluated by cultivating cells in maintenance medium containing concentrations of test compounds as described in a previous paper (De Clercq, 1985) . The concentration required to cause a microscopically detectable alteration of normal cell morphology was estimated as the minimum cytotoxic concentration (MCC).
